Also trades as: 0JBU.L (LSE) · $vol 0M
NTLA Smart Money
Intellia Therapeutics, Inc.
1W: -2.8%
1M: -4.2%
3M: +3.4%
YTD: +22.3%
1Y: -56.5%
3Y: -58.5%
5Y: -91.4%
$12.28
+1.02 (+9.06%)
After Hours: $12.19 (-0.09, -0.73%)
Weekly Expected Move ±8.1%
$9
$10
$11
$12
$13
Credit Risk of going bust: higher than 68% of companies Debt: 4.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.10 (down 99.1%), Intellia Therapeutics, Inc. would be worth roughly what it owes.
Total debt $73.4M against a stock market value of $1.58B.
Distance to default 3.59 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $36.7M (short-term plus half of long-term), stock volatility 96.2%; Altman Z'' -4.42. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.10 (down 99.1%), Intellia Therapeutics, Inc. would be worth roughly what it owes.
Total debt $73.4M against a stock market value of $1.58B.
Distance to default 3.59 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $36.7M (short-term plus half of long-term), stock volatility 96.2%; Altman Z'' -4.42. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026365
Institutions Holding
+10 vs prior
155.5%
Ownership
+66.15%
57
New
140
Increased
108
Reduced
29
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Dube Michael P | officer: vp, chief accounting officer | S-Sale | 1,864 | $12.43 | $23K | Filing |
| 2026-08-21 | LEONARD JOHN M | officer: president and ceo | S-Sale | 2,785 | $13.00 | $36K | Filing |
| 2026-08-20 | LEONARD JOHN M | officer: president and ceo | S-Sale | 19,890 | $12.60 | $251K | Filing |
| 2026-07-22 | Dulac Edward J III | officer: evp, chief financial officer | S-Sale | 8,111 | $11.25 | $91K | Filing |
| 2026-07-02 | Dulac Edward J III | officer: evp, chief financial officer | S-Sale | 4,677 | $18.00 | $84K | Filing |
| 2026-07-01 | Dube Michael P | officer: vp, chief accounting officer | S-Sale | 2,641 | $16.78 | $44K | Filing |
| 2026-06-09 | GOODMAN JESSE | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | Goff Brian | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | Cohen Fred E | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | CHASE WILLIAM J | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | Bhanji Muna | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | Verwiel Frank | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-06-09 | Keresty Georgia | director | A-Grant/Award | 9,200 | $— | $0 | Filing |
| 2026-03-02 | BASTA JAMES | officer: evp, general counsel | S-Sale | 1,211 | $13.78 | $17K | Filing |
| 2026-03-02 | Clark Eliana | officer: evp, chief technical officer | S-Sale | 607 | $13.78 | $8K | Filing |
| 2026-03-01 | Dulac Edward J III | officer: evp, chief financial officer | A-Grant/Award | 61,280 | $— | $0 | Filing |
| 2026-03-01 | Schultes Birgit C | officer: evp, chief scientific officer | A-Grant/Award | 39,200 | $— | $0 | Filing |
| 2026-03-01 | Lebwohl David | officer: evp, chief medical officer | A-Grant/Award | 9,943 | $— | $0 | Filing |
| 2026-03-01 | LEONARD JOHN M | officer: president and ceo | A-Grant/Award | 156,400 | $— | $0 | Filing |
| 2026-03-01 | Dube Michael P | officer: vp, chief accounting officer | A-Grant/Award | 17,250 | $— | $0 | Filing |
| 2026-03-01 | Clark Eliana | officer: evp, chief technical officer | A-Grant/Award | 7,353 | $— | $0 | Filing |
| 2026-03-01 | BASTA JAMES | officer: evp, general counsel | A-Grant/Award | 46,080 | $— | $0 | Filing |
| 2026-01-05 | Lebwohl David | officer: evp, chief medical officer | S-Sale | 11,903 | $9.21 | $110K | Filing |
| 2026-01-05 | Dulac Edward J III | officer: evp, chief financial officer | S-Sale | 6,379 | $9.21 | $59K | Filing |
| 2026-01-05 | BASTA JAMES | officer: evp, general counsel | S-Sale | 10,397 | $9.21 | $96K | Filing |
🏛️ Congressional Trades
25 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2023-08-25 | Thomas R. Carper | Senate | Sell | $1,001 - $15,000 | Filing |
| 2023-08-25 | Thomas Richard Carper | Senate | Sell | $1,001 - $15,000 | Filing |
| 2023-08-25 | Thomas R. Carper | Senate | Sell | $1,001 - $15,000 | Filing |
| 2023-05-22 | Thomas Richard Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2023-05-22 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2023-05-22 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2022-02-28 | Donald Sternoff Beyer | House | Sell | $15,001 - $50,000 | Filing |
| 2021-10-29 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2021-09-20 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2021-07-21 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2021-01-15 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas Richard Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas Richard Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-20 | Thomas R. Carper | Senate | Buy | $1,001 - $15,000 | Filing |
| 2020-11-18 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2020-08-26 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2020-07-10 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2020-01-14 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2018-10-25 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2018-10-25 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 16,875,684 | $286M | +2,366,437 | 2026-06-30 | Filing |
| BlackRock, Inc. | 15,409,023 | $261M | +3,253,217 | 2026-06-30 | Filing |
| STATE STREET CORP | 9,234,987 | $156M | +2,312,311 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,332,401 | $124M | +1,109,076 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 6,443,323 | $109M | +715,146 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,028,586 | $102M | +944,481 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 5,235,348 | $89M | +529,447 | 2026-06-30 | Filing |
| FMR LLC | 4,773,034 | $81M | +2,705,812 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 4,526,926 | $77M | +4,526,926 | 2026-06-30 | Filing |
| REGENERON PHARMACEUTICALS, INC. | 3,702,995 | $63M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,631,061 | $61M | +779,589 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3,280,760 | $56M | +1,883,517 | 2026-06-30 | Filing |
| Amova Asset Management Americas, Inc. | 2,897,529 | $49M | +924,468 | 2026-06-30 | Filing |
| Sumitomo Mitsui Trust Group, Inc. | 2,897,529 | $49M | +924,468 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,602,944 | $44M | +284,834 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,264,471 | $38M | +636,230 | 2026-06-30 | Filing |
| UBS Group AG | 2,152,912 | $36M | -536,574 | 2026-06-30 | Filing |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 2,066,356 | $35M | +454,822 | 2026-06-30 | Filing |
| Contrarius Group Holdings Ltd | 1,955,228 | $33M | +43,389 | 2026-06-30 | Filing |
| JUPITER ASSET MANAGEMENT LTD | 1,849,507 | $31M | +68,444 | 2026-06-30 | Filing |